The New "Prescriber Notes" Requirement: What Personalization Actually Looks Like on Your Rx

Post-ruling, prescriber notes on compounded GLP-1 prescriptions have gotten longer and more specific. Here's what those notes actually contain, why the language matters, and how to read your own prescription record.

What Changed

Before mid-2025, a compounded semaglutide prescription might have been as sparse as: "Compounded semaglutide 2.5 mg/mL, inject weekly, quantity 3 vials." Post-ruling, that same prescription now typically carries a paragraph of prescriber notes documenting the personalization basis for compounding.

The change wasn't cosmetic. Regulators clarified that a 503A compounded product needs a documented, patient-specific clinical basis — and prescribers responded by writing those bases explicitly into the Rx record.

What Personalization Notes Actually Contain

Modern prescriber notes on compounded GLP-1 prescriptions typically address at least one of the following:

• Dose personalization: Patient requires a dose between commercially available strengths (e.g., 0.35 mg weekly, between the 0.25 mg and 0.5 mg brand pens).
• Titration flexibility: Patient experienced tolerance issues at standard brand titration and needs a slower or non-standard schedule.
• Formulation need: Patient has documented sensitivity to a component of the commercial formulation, or requires a combination product (e.g., semaglutide + B12/cyanocobalamin) not commercially available.
• Route personalization: Patient requires a different route than commercial product (e.g., oral drops when injection isn't feasible).

How to Read Your Own Prescription

Most telehealth platforms give patients access to their prescription details through the patient portal. Look for the section labeled "prescriber notes," "clinical rationale," or "compounding basis." It should identify at least one of the personalization categories above with specific reference to your intake information.

If your prescription doesn't include such notes, or if the notes are boilerplate language that could apply to any patient, that's a signal worth raising with the platform's care team. Well-run platforms will document properly on request.

Why the Documentation Matters to You

Two practical reasons. First, if your pharmacy is audited or receives a regulatory inquiry, documented personalization is what makes your prescription defensible. A pharmacy with well-documented Rx records is less likely to face disruption. Second, if you switch pharmacies later, the personalization documentation carries with you — the new pharmacy can honor the same clinical basis rather than requiring an entirely new evaluation.

The Prescriber's Perspective

Writing personalization notes takes prescribers time, and time is billed. Some platforms have absorbed the additional documentation burden into existing consult fees. Others have added a small fee for compounded prescriptions specifically. Either way, the additional documentation is now standard practice at well-run platforms — a pattern you should expect and welcome.

Where to Start